ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
about
Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-AnalysesBacterial Infections in Hematopoietic Stem Cell Transplant RecipientsVaccine approaches for multidrug resistant Gram negative infectionsThe global threat of antimicrobial resistance: science for interventionInhaled Antibiotics for Gram-Negative Respiratory InfectionsApplication of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care UnitTreatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model.The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation.Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?Screening and contact precautions - A survey on infection control measures for multidrug-resistant bacteria in German university hospitalsMolecular epidemiological survey of bacteremia by multidrug resistant Pseudomonas aeruginosa: the relevance of intrinsic resistance mechanisms.Efficacy of surface disinfectant cleaners against emerging highly resistant gram-negative bacteria.Back to basics: hand hygiene and isolation.Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an intensive care unit with no single roomsDifferences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison studyControlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination.Rapid detection of extended-spectrum-β-lactamase-producing enterobacteriaceae from urine samples by use of the ESBL NDP test.Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study.Colonization with Multi-Drug Resistant Organisms in Nursing Homes: Scope, Importance, and ManagementRapid detection of ESBL-producing Enterobacteriaceae in blood cultures.Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental studyDissemination of high-risk clones of extensively drug-resistant Pseudomonas aeruginosa in colombia.Combatting resistance in intensive care: the multimodal approach of the Spanish ICU "Zero Resistance" program.Gambogic Acid Disrupts Toll-like Receptor4 Activation by Blocking Lipopolysaccharides Binding to Myeloid Differentiation Factor 2.Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains.First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs.Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy.Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol.Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008-2013Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combinationSusceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infectionAdherence to Hospital Antibiotic Policy for Treatment of Escherichia coli ESBL in Urine.Structural Divergence of the Group I Intron Binding Surface in Fungal Mitochondrial Tyrosyl-tRNA Synthetases That Function in RNA Splicing.Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.Infection Risk in Sterile Operative Procedures.Effectiveness of Washing Procedures in Reducing Salmonella enterica and Listeria monocytogenes on a Raw Leafy Green Vegetable (Eruca vesicaria).Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting.Whole-Genome Multilocus Sequence Typing of Extended-Spectrum-Beta-Lactamase-Producing EnterobacteriaceaeHow to measure the impacts of antibiotic resistance and antibiotic development on empiric therapy: new composite indices.
P2860
Q26781236-504A520C-F4E8-4A8E-91C0-3F826E88B5F2Q26799576-9C1CE397-414D-4CF8-9AF6-BAA29114BC78Q27007042-1E7141F8-3DFC-4807-B675-F15E78BE821FQ28083609-9E34BC88-27CE-4E45-AB65-DFB6132AE17FQ28386160-16EFF0F9-F6DF-4082-BCB2-ABF0E543B416Q28555082-BED50A81-E972-45FA-8C91-D71EDEDACFDDQ30277636-4F103561-540D-46CA-ABE2-5836313604BDQ30375493-1463A1F0-9F7E-4482-BBE8-082FEEB499D1Q33555383-5FD905D2-EFCB-4413-953B-EBB825DDE074Q33560675-CFDE8A93-13A9-45E7-8AC1-3B85817DA5DAQ33648133-E3551BF8-976C-4D0C-B553-BD9BECFEC1F4Q33777562-C12BB9DA-F08E-4734-B5D4-02334907DE78Q33863441-01384458-D94F-4A4C-A192-302BAD0A4D0DQ33867062-8D18C2F9-4A97-4AF4-92F2-3C480A84277FQ34198942-9C3ABB77-0155-467B-9D67-17A6CBEB78A9Q34297673-BA7CFA9E-2EE8-4213-8872-4C1E2D9DAA7DQ34298270-FEE276FE-2263-478D-98BC-2FDA04DA9C90Q34700642-64F8B181-DD0A-47CC-8C2B-42402BCB382FQ35049907-B201FCC0-97D4-4D21-89F2-71BB1C969CC1Q35130334-6A72BA5E-7B70-4AC5-B94F-75A3A5146DD2Q35131933-12543E56-9F58-4736-B692-E75FF60D6693Q35168972-27CF9BE6-7BAA-401C-8D6E-E2C1D46BA05FQ35181034-124FD8EA-F1AC-4F69-8EF3-2E0792C46762Q35397370-7210B52E-9565-4125-9DFF-D9FD2767450FQ35607885-38A5DE6C-613E-4CE3-AC50-68F08AD16917Q35750812-8E8565B7-DEC0-495C-9DD8-B2E635A25C24Q35805642-881B05F2-6A0A-48F9-ADE8-FD519BE1B713Q35975439-59262B1A-E88F-4ABF-B864-911CF171A940Q36241590-24150FC5-970D-4506-8E5A-F9422B8ED395Q36246604-61D71075-D6EE-418D-8D27-1A8433C9EC41Q36270659-2A0940CD-F2C9-4994-B9A5-0C80C7CDCA10Q36377350-AC1436E1-400F-4C21-8891-7313F0B40703Q36830992-688F06ED-06B9-48A9-86D9-DFEFDAD36FF8Q36941149-09239044-8BD8-47AC-BC54-A67CCC1447CFQ37016637-D322E39F-E3DC-47D6-8CD5-EECC089B4C88Q37176640-D2A0AD10-05D9-40F6-A81A-09836F184DA6Q37352560-5A5CDF5B-3A49-4F62-8296-B4212C2F1C9EQ37434270-0DF1EAE5-F86D-4604-8D36-2FD3D26A8013Q37434290-17BC4F2C-B343-4341-A528-AAD6C9792596Q37517286-7937B517-01E3-49F7-A2D3-79AD5A8E7152
P2860
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
ESCMID guidelines for the mana ...... teria in hospitalized patients
@ast
ESCMID guidelines for the mana ...... teria in hospitalized patients
@en
ESCMID guidelines for the mana ...... teria in hospitalized patients
@nl
type
label
ESCMID guidelines for the mana ...... teria in hospitalized patients
@ast
ESCMID guidelines for the mana ...... teria in hospitalized patients
@en
ESCMID guidelines for the mana ...... teria in hospitalized patients
@nl
prefLabel
ESCMID guidelines for the mana ...... teria in hospitalized patients
@ast
ESCMID guidelines for the mana ...... teria in hospitalized patients
@en
ESCMID guidelines for the mana ...... teria in hospitalized patients
@nl
P2093
P50
P921
P3181
P356
P1476
ESCMID guidelines for the mana ...... teria in hospitalized patients
@en
P2093
E Tacconelli
European Society of Clinical Microbiology
G Kahlmeter
M A Cataldo
M Venditti
S J Dancer
P3181
P356
10.1111/1469-0691.12427
P407
P478
20 Suppl 1
P577
2014-01-01T00:00:00Z